This document summarizes findings from the National Health and Nutrition Examination Survey (NHANES) on vitamin D status in the U.S. population from 2001-2006. It finds that two-thirds of the population had sufficient vitamin D levels, while about one-quarter were at risk of inadequacy and 8% were at risk of deficiency. The risk of deficiency varied by age, sex, race, and pregnancy status. Between 1988-1994 and 2001-2002, the risk of deficiency increased in both sexes but did not change further between survey periods. The document analyzes vitamin D status based on recent Institute of Medicine guidelines.
GHME 2013 Conference
Session: Global Burden of Diseases, Injuries, and Risk Factors Study 2010: workshop on methods and key findings
Date: June 18 2013
Presenter: Rafael Lozano
Institute:
Institute for Health Metrics and Evaluation (IHME), University of Washington
From the CDC why it is so important to wake up and be proactive before the reactive healthcare become a reality. Hospitalization, Doctors, Medicines are for the most part concerned with symptoms. We are excited to share a plan that works quickly, burns up belly fat and teaches new habits of eating moving forward that will lead you into a healthy, lean lifestyle so that you keep the fat off for the rest of your life!
Cancer and US Latinos
Daniel Santibanez, MPH, University of North Florida
June 24, 2005 - UNF Hispanic Health Issues Seminar
This is part 5 of an 8 part series of seminars on Hispanic Health Issues brought to you by the University of North Florida’s Dept. of Public Health, College of Health, a grant from AETNA, and the cooperation of Duval County Health Department.
GHME 2013 Conference
Session: Global Burden of Diseases, Injuries, and Risk Factors Study 2010: workshop on methods and key findings
Date: June 18 2013
Presenter: Rafael Lozano
Institute:
Institute for Health Metrics and Evaluation (IHME), University of Washington
From the CDC why it is so important to wake up and be proactive before the reactive healthcare become a reality. Hospitalization, Doctors, Medicines are for the most part concerned with symptoms. We are excited to share a plan that works quickly, burns up belly fat and teaches new habits of eating moving forward that will lead you into a healthy, lean lifestyle so that you keep the fat off for the rest of your life!
Cancer and US Latinos
Daniel Santibanez, MPH, University of North Florida
June 24, 2005 - UNF Hispanic Health Issues Seminar
This is part 5 of an 8 part series of seminars on Hispanic Health Issues brought to you by the University of North Florida’s Dept. of Public Health, College of Health, a grant from AETNA, and the cooperation of Duval County Health Department.
This is a study using historical data and forecasts of life expectancy for several countries. The data and forecasts come from the UN - Population Division. While the historical data is most interesting, the forecasts are highly optimistic as they project a linear trend way into the future. Meanwhile, those forecasts should have followed a much more realistic logarithmic curve reflecting slower increase in life expectancy as the life expectancy rises.
GHME 2013 Conference
Session: Global and national Burden of Disease II
Date: June 17 2013
Presenter: Kyle Heuton
Institute:
Institute for Health Metrics and Evaluation (IHME), University of Washington
Vitamin D Deficiency in Association with HSCRP Linked to Obesityijtsrd
Vitamin D deficiency is gaining increasing attention for its novel association with Obesity. Studies have found that maintaining vitamin D status may reduce ones risk of developing various diseases. Background In 2010, overweight and obesity were estimated to cause 3"¢4 million deaths, 3"¢9 of years of life lost, and 3"¢8 of disability-adjusted life-years DALYs worldwide. The rise in obesity has led to widespread calls for regular monitoring of changes in overweight and obesity prevalence in all populations. The treatment of obesity and cardiovascular diseases is one of the most difficult and important challenges nowadays. This paper seeks to examine the consistently reported relationship between obesity and low vitamin D concentrations in association with HSCRP, with reference to the possible underlying mechanisms. The possibility that vitamin D may assist in preventing or treating obesity is also examined and recommendations for future research are made. We tested the hypothesis that suggests Adults with severe obesity have lower 25-hydroxyvitamin D levels will have higher hs-CRP levels. Dr. Pushpamala Ramaiah | Dr. Ayman Johargy | Dr. Lamiaa Ahmed Elsayed | Dr. Grace Lindsey "Vitamin D Deficiency in Association with HSCRP Linked to Obesity" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-2 | Issue-6 , October 2018, URL: http://www.ijtsrd.com/papers/ijtsrd18479.pdf
Dr. Rakesh K. Srivastava
Dr. Rakesh K. Srivastava (Ph.D., FRSM, FRSPH) is the name which has highest value that holds as the professor and scientist. He has the years of the expertise in the field of science and medicine. Dr. Srivastava understands the science in such way that will help the others to know the best.
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)Innovara, Inc.
A presentation on cancer and ethnicity in the United States, and how the US can learn from other countries in regards to cancer control. - by Barri Blauvelt, CEO, Innovara, Inc.
Cancer and other noncommunicable diseases (NCDs) arenowwidely recognized as a threat to global development.The latest United Nations high-level meeting on NCDs reaffirmed thisc observation and also highlighted the slow progress in meeting the 2011 Political Declarationon the Prevention and Control of Noncommunicable Diseases and the third Sustainable Development Goal. Lack of situational analyses, priority setting,and budgeting have been identified as major obstacles in achieving these goals. All of these have incommon that they require information on the local cancer epidemiology.
The Global Burden of Disease (GBD) study is uniquely poised to provide these crucial data.
Dr. Ali Mokdad from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington presents the latest U.S. County Life Expectancy estimates from 1989 to 2009, at the Association of Health Care Journalists conference in Atlanta, GA, April 19, 2012.
Higher expression of SATB2 in hepatocellular carcinoma of African Americans d...rakeshsrivastava89
Abstract
In the United States, Hepatocellular Carcinoma (HCC) incidence has tripled over the past two decades. The disease has disproportionately affected minority and disadvantaged
populations. The purpose of this study was to examine the expression of SATB2 gene in HCC cells derived from African Americans (AA) and Caucasian Americans (CA) and assess its oncogenic potential by measuring cell viability, spheroid
formation, epithelial‐mesenchymal transition (EMT), stem cell markers and pluripotency maintaining factors in cancer stem cells (CSCs). We compared the expression of SATB2 in human primary hepatocytes, HCC cells derived from AA and CA, and
HCC CSCs. Hepatocellular carcinoma cells derived from AA expressed the higher level of SATB2 than those from CA. By comparison, normal human hepatocytes did
not express SATB2. Higher expression of SATB2 in HCC cells from AA was associated with greater growth rate, cell viability, colony formation and EMT characteristics than those from CA. Knockout of SATB2 in CSCs by Crispr/Cas9 technique significantly inhibited the expression of SATB2 gene, stem cell markers (CD24, CD44 and CD133), pluripotency maintaining factors (c‐Myc, KLF4, SOX2 and OCT4), and EMT
compared with non‐targeting control group. The expression of SATB2 was negatively correlated with miR34a. SATB2 rescued the miR‐34a‐mediated inhibition of CSC's viability. These data suggest that SATB2 is an oncogenic factor, and its higher expression may explain the disparity in HCC outcomes among AA.
Wei Yu1 | Sanjit K. Roy2 | Yiming Ma1 | Thomas A. LaVeist3 | Sharmila Shankar1,2,4 |
Rakesh K. Srivastava1,2,4
This is a study using historical data and forecasts of life expectancy for several countries. The data and forecasts come from the UN - Population Division. While the historical data is most interesting, the forecasts are highly optimistic as they project a linear trend way into the future. Meanwhile, those forecasts should have followed a much more realistic logarithmic curve reflecting slower increase in life expectancy as the life expectancy rises.
GHME 2013 Conference
Session: Global and national Burden of Disease II
Date: June 17 2013
Presenter: Kyle Heuton
Institute:
Institute for Health Metrics and Evaluation (IHME), University of Washington
Vitamin D Deficiency in Association with HSCRP Linked to Obesityijtsrd
Vitamin D deficiency is gaining increasing attention for its novel association with Obesity. Studies have found that maintaining vitamin D status may reduce ones risk of developing various diseases. Background In 2010, overweight and obesity were estimated to cause 3"¢4 million deaths, 3"¢9 of years of life lost, and 3"¢8 of disability-adjusted life-years DALYs worldwide. The rise in obesity has led to widespread calls for regular monitoring of changes in overweight and obesity prevalence in all populations. The treatment of obesity and cardiovascular diseases is one of the most difficult and important challenges nowadays. This paper seeks to examine the consistently reported relationship between obesity and low vitamin D concentrations in association with HSCRP, with reference to the possible underlying mechanisms. The possibility that vitamin D may assist in preventing or treating obesity is also examined and recommendations for future research are made. We tested the hypothesis that suggests Adults with severe obesity have lower 25-hydroxyvitamin D levels will have higher hs-CRP levels. Dr. Pushpamala Ramaiah | Dr. Ayman Johargy | Dr. Lamiaa Ahmed Elsayed | Dr. Grace Lindsey "Vitamin D Deficiency in Association with HSCRP Linked to Obesity" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-2 | Issue-6 , October 2018, URL: http://www.ijtsrd.com/papers/ijtsrd18479.pdf
Dr. Rakesh K. Srivastava
Dr. Rakesh K. Srivastava (Ph.D., FRSM, FRSPH) is the name which has highest value that holds as the professor and scientist. He has the years of the expertise in the field of science and medicine. Dr. Srivastava understands the science in such way that will help the others to know the best.
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)Innovara, Inc.
A presentation on cancer and ethnicity in the United States, and how the US can learn from other countries in regards to cancer control. - by Barri Blauvelt, CEO, Innovara, Inc.
Cancer and other noncommunicable diseases (NCDs) arenowwidely recognized as a threat to global development.The latest United Nations high-level meeting on NCDs reaffirmed thisc observation and also highlighted the slow progress in meeting the 2011 Political Declarationon the Prevention and Control of Noncommunicable Diseases and the third Sustainable Development Goal. Lack of situational analyses, priority setting,and budgeting have been identified as major obstacles in achieving these goals. All of these have incommon that they require information on the local cancer epidemiology.
The Global Burden of Disease (GBD) study is uniquely poised to provide these crucial data.
Dr. Ali Mokdad from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington presents the latest U.S. County Life Expectancy estimates from 1989 to 2009, at the Association of Health Care Journalists conference in Atlanta, GA, April 19, 2012.
Higher expression of SATB2 in hepatocellular carcinoma of African Americans d...rakeshsrivastava89
Abstract
In the United States, Hepatocellular Carcinoma (HCC) incidence has tripled over the past two decades. The disease has disproportionately affected minority and disadvantaged
populations. The purpose of this study was to examine the expression of SATB2 gene in HCC cells derived from African Americans (AA) and Caucasian Americans (CA) and assess its oncogenic potential by measuring cell viability, spheroid
formation, epithelial‐mesenchymal transition (EMT), stem cell markers and pluripotency maintaining factors in cancer stem cells (CSCs). We compared the expression of SATB2 in human primary hepatocytes, HCC cells derived from AA and CA, and
HCC CSCs. Hepatocellular carcinoma cells derived from AA expressed the higher level of SATB2 than those from CA. By comparison, normal human hepatocytes did
not express SATB2. Higher expression of SATB2 in HCC cells from AA was associated with greater growth rate, cell viability, colony formation and EMT characteristics than those from CA. Knockout of SATB2 in CSCs by Crispr/Cas9 technique significantly inhibited the expression of SATB2 gene, stem cell markers (CD24, CD44 and CD133), pluripotency maintaining factors (c‐Myc, KLF4, SOX2 and OCT4), and EMT
compared with non‐targeting control group. The expression of SATB2 was negatively correlated with miR34a. SATB2 rescued the miR‐34a‐mediated inhibition of CSC's viability. These data suggest that SATB2 is an oncogenic factor, and its higher expression may explain the disparity in HCC outcomes among AA.
Wei Yu1 | Sanjit K. Roy2 | Yiming Ma1 | Thomas A. LaVeist3 | Sharmila Shankar1,2,4 |
Rakesh K. Srivastava1,2,4
CORONARY ARTERY DISEASE is a modern epidemic in india. due to changes in living conditions and habits its prevalence is increasing day by day . in this presentation i have explained the various risk factors and innovations in diagnosis of CAD. IT is very useful for primary health care physicians and community medicine specialist
Prevalence of anemia and socio-demographic factors associated with anemia amo...IOSR Journals
Objective: To study the prevalence of anemia and socio-demographic factors associated with anemia among pregnant women attending antenatal hospital. Material and methods: Total 100 pregnant women were selected for the study and the study was carried out from Sep 2011 to Jan 2012. Pretested and prestructured questionnaire was used to collect general information. Blood samples were collected by qualified technician for hemoglobin estimation. Socio-economic classification by B.G. Prasad was adopted. Classification of anemia by WHO was used. Chi-square test was used for statistical analysis. Results: Overall prevalence of anemia among the pregnant women was found to be 63%. Factors such as level of education and socio-economic status were found to be significantly associated with prevalence of anemia. Conclusion: There is a need for realization that health system should focus on various factors that contribute to the occurrence of anemia and include them as important mediators in the National Health Policy.
Effects of raising vit D levels on birth complications
"Differences by race/ethnicity were not statistically significant when 25(OH)D concentration was included as a covariate in multivariable regression analysis."
Risk factors in Multiple Sclerosis: Detection and Treatment in Daily Life
Caroline Pot and Patrice Lalive
Unit of Neuroimmunology and Multi Sclerosis Geneva University Hospital
The Effect Race and Income on HIV AIDS infection in African-Americans - Sunil...Sunil Nair
Race and Income has a significant influence on susceptibility to HIV/AIDS infections; Afro-Americans (Blacks) are 1.33 times more likely to be infected than whites. A significant finding is that the income level didn't change race's effect on HIV infections. Race has a significant effect on HIV infections or is an important predictor of incidence of HIV infections independent of the income. In other words, irrespective of the income level being black and poor increases the changes of being infected with HIV/AIDS.
Chapter 4
Descriptive Epidemiology: Person, Place, Time
Learning Objectives
State primary objectives of descriptive epidemiology
Provide examples of descriptive studies
List characteristics of person, place, and time
Characterize the differences between descriptive and analytic epidemiology
Descriptive vs. Analytic Epidemiology
Descriptive studies--used to identify a health problem that may exist. Characterize the amount and distribution of disease
Analytic studies--follow descriptive studies, and are used to identify the cause of the health problem
2
Objectives of Descriptive Epidemiology
To evaluate and compare trends in health and disease
To provide a basis for planning, provision, and evaluation of health services
To identify problems for analytic studies (creation of hypotheses)
3
Descriptive Studies and Epidemiologic Hypotheses
Hypotheses--theories tested by gathering facts that lead to their acceptance or rejection
Three types:
Positive declaration (research hypothesis)
Negative declaration (null hypothesis)
Implicit question (e.g., to study association between infant mortality and region)
4
Mill’s Canons of Inductive Reasoning
The method of difference--all the factors in two or more places are the same except for a single factor.
The method of agreement--a single factor is common to a variety of settings. Example: air pollution.
5
Mill’s Canons (cont’d)
The method of concomitant variation--the frequency of disease varies according to the potency of a factor.
The method of residues--involves subtracting potential causal factors to determine which factor(s) has the greatest impact.
6
Method of Analogy
(MacMahon and Pugh)
The mode of transmission and symptoms of a disease of unknown etiology bear a pattern similar to that of a known disease.
This information suggests similar etiologies for both diseases.
Three Approaches to Descriptive Epidemiology
Case reports--simplest category of descriptive epidemiology
Case series
Cross-sectional studies
Case Reports and Case Series
Case reports--astute clinical observations of unusual cases of disease
Example: a single occurrence of methylene chloride poisoning
Case series--a summary of the characteristics of a consecutive listing of patients from one or more major clinical
Example: five cases of hantavirus pulmonary syndrome
7
Cross-sectional Studies
Surveys of the population to estimate the prevalence of a disease or exposure
Example: National Health Interview Survey
Characteristics of Persons Covered in Chapter 4
Age
Sex
Marital Status
Race and ethnicity
Nativity and migration
Religion
Socioeconomic status
Age
One of the most important factors to consider when describing the occurrence of any disease or illness
8
Trends by Age Subgroup
Childhood to early adolescence
Leading cause of death, ages 1-14 years—unintentional injuries
Infants—mortality from developmental problems, e.g., congenital birth defects
Ch ...
The rate of alcohol-related deaths has accelerated in recent years, according to a new analysis of U.S. mortality data between 2000-2016. Here's more:
•Overall trends: There were more than 425,000 alcohol-induced deaths during the study period. The annual percentage change in such deaths increased among both men and women, but rose significantly starting in 2012.
•Demographics: Starting in 2012, men experienced a 4.2% annual increase in alcohol-related deaths. From 2013-2016, women experienced an annual percentage increase of around 7%. American Indian and Alaska Native women experienced the highest increases over the 17-year study period.
•Causes: Alcoholic liver disease accounted for the majority of deaths among men and women, followed by mental or physical disorders due to alcohol and accidental poisoning.
Mortality and Morbidity what are the major health problems in.docxgilpinleeanna
Mortality and Morbidity: what are the major health problems in the developing world?
On one hand, people in low-income countries are much worse off, and much more likely to die
prematurely, than people in wealthier parts of the world. On the other hand, it's important to
note that those who live past age five have strong chances of living to the age of 60 ; saving a life
from even a single cause of death means saving a person who is likely to live significantly longer.
Children under five in low-income countries primarily die of preventable and treatable diseases
such as malaria, respiratory infections, diarrhea, perinatal conditions, measles, and HIV/AIDS.
Between the ages of 5 and 60, the major causes of death in low-income countries (relative to
higher-income countries) are HIV/AIDS, tuberculosis, and maternal mortality (i.e., deaths in
childbirth). After the age of 60, there are large differences in the mortality rates for many of the
same causes of death that affect those under 5, as well as for many conditions that require
advanced medical attention (heart disease, cancer, diabetes).
The table below shows the differences between low-income and high-income countries, in
terms of deaths per 1,000, by age range and cause of death. It is color-coded: yellow squares
represent causes of death for which mortality rates are greater in low-income countries by at
least 0.5 deaths per 1,000 people, orange squares represent causes of death for which mortality
rates are greater in low-income countries by at least 1 deaths per 1,000 people), and red
squares represent causes of death for which mortality rates are greater in low-income countries
by at least 2.5 deaths per 1,000 people.
1
Note that conditions vary within the developing world. Mortality rates for many causes are
higher in Sub-Saharan Africa than in the group of low-income countries (which includes some
highly populous Asian countries, such as India, Pakistan, and Bangladesh).
Non-fatal health problems
Household surveys of those living on under $1 or $2 per day show that the poor are often sick.
In the surveys cited by Banerjee and Duflo (2006), in every country for which data was available
an average of over 10% of households reported at least one member needed to see a doctor in
the month prior to the survey. In many areas the average exceeded 25%; parts of India, Mexico,
and Nicaragua had averages above 35%. Here we do not discuss all health problems in detail,
but we present three prevalent conditions (malnutrition, parasitic worms, and malaria) which
are both direct causes of symptoms and risk factors for other conditions. In addition, we
present data on the prevalence of a selection of health problems that are common in low-
income countries and compare prevalence rates in these countries to rates in high-income
countries.
Malnutrition is a widespread pro ...
Small Arms Lethality variables 1.6e DRAFTJA Larson
small arms lethality is a complex equation.
military operations are generally a team event.....more like football or soccer than tennis......
therefore teamwork and safety adds complexity
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
1. NCHS Data Brief ■ No. 59 ■ March 2011
u.s. department of health and human services
Centers for Disease Control and Prevention
National Center for Health Statistics
Vitamin D Status: United States, 2001–2006
Anne C. Looker, Ph.D.; Clifford L. Johnson, M.P.H.; David A. Lacher, M.D.; Christine M. Pfeiffer, Ph.D.;
Rosemary L. Schleicher, Ph.D.; and Christopher T. Sempos, Ph.D.
The Institute of Medicine (IOM) recently released new dietary reference
intakes for calcium and vitamin D (1). The IOM defined four categories of
vitamin D status based on serum 25-hydroxyvitamin D (25OHD): (i) risk
of deficiency, (ii) risk of inadequacy, (iii) sufficiency, and (iv) above which
there may be reason for concern (1). This brief presents the most recent
national data on vitamin D status in the U.S. population based on these IOM
categories. Results are presented by age, sex, race and ethnicity, and, for
women, by pregnancy and lactation status.
Keywords: serum 25-hydroxyvitamin D • prevalence • deficiency • inadequacy
In 2001–2006, what was the vitamin D status of the U.S.
population based on the IOM thresholds for serum 25OHD?
In 2001–2006, two-thirds (67%) of persons aged 1 year and over had serum
25OHD values considered sufficient (Figure 1). Roughly one quarter of the
population had serum 25OHD values that put them at risk of inadequacy.
Eight percent were at risk of deficiency, and 1% had a high serum 25OHD
value that may possibly be harmful. Serum 25OHD percentile values, which
provide a more detailed description of the serum 25OHD distribution in the
U.S. population, are shown in the Table.
Key findings
Data from the National
Health and Nutrition
Examination Surveys
(NHANES)
In 2001–2006, two-thirds of•
the population had sufficient
vitamin D, defined by the
Institute of Medicine as a
serum 25-hydroxyvitamin D
(25OHD) value of 50–125
nmol/L. About one-quarter
were at risk of vitamin D
inadequacy (serum 25OHD
30–49 nmol/L), and 8% were
at risk of vitamin D deficiency
(serum 25OHD less than 30
nmol/L).
The risk of vitamin D•
deficiency differed by age,
sex, and race and ethnicity.
The prevalence was lower in
persons who were younger,
male, or non-Hispanic
white. Among women, the
prevalence at risk was also
lower in pregnant or lactating
women.
The risk of vitamin D•
deficiency increased between
1988–1994 and 2001–2002 in
both sexes but did not change
between 2001–2002 and
2005–2006.
2. NCHS Data Brief ■ No. 59 ■ March 2011
■ 2 ■
Table. Selected percentile values for serum 25-hydroxyvitamin D (25OHD), by sex and age, and by pregnancy
and lactation status in females: United States, 2001–2006
Serum 25OHD (nmol/L) percentile
Characteristic n 5th 10th 25th 50th 75th 90th 95th
Male
Age (years)
1–3 581 40.7 48.3 58.2 69.5 84.4 94.7 101.0
4–8 970 42.6 47.8 58.0 67.3 78.8 92.0 99.9
9–13 1,473 32.5 40.4 49.9 62.1 74.5 87.4 98.5
14–18 1,978 25.3 33.0 45.7 58.5 71.2 84.9 95.7
19–30 1,611 23.0 29.4 41.9 55.3 68.7 83.6 94.3
31–50 2,244 25.1 31.3 44.2 57.4 71.5 84.5 94.3
51–70 1,853 25.6 32.7 44.1 58.1 71.3 83.7 91.8
Over 70 1,217 25.4 31.7 44.6 57.2 69.7 82.7 90.1
Female
Age (years)
1–3 584 43.3 49.8 58.5 68.3 79.4 89.2 94.9
4–8 989 38.4 44.2 54.5 67.2 80.0 93.4 101.0
9–13 1,515 27.7 34.6 46.3 57.6 68.4 80.9 87.5
14–18 1,823 20.8 27.2 41.1 57.2 71.6 87.1 104.0
19–30 1,346 18.5 25.4 40.0 55.9 76.2 95.6 111.0
31–50 2,097 19.2 25.3 38.9 55.3 71.0 87.6 101.0
51–70 1,866 21.2 27.0 39.7 54.7 69.7 85.4 93.4
Over 70 1,197 22.6 27.1 40.5 55.5 69.6 84.1 93.6
Pregnant or
lactating
1,067 24.5 31.4 44.5 62.4 78.2 94.7 109.0
SOURCE: CDC/NCHS, National Health and Nutrition Examination Survey (NHANES), 2001–2006; data for ages 1–5 years from NHANES 2003–2006.
What is the prevalence of serum 25OHD values indicating risk of deficiency,
by age and sex?
The season-adjusted prevalence at risk of deficiency by age ranged from 1% to 8% in males and
1% to 12% in females (Figure 2). In both sexes, the prevalence was lowest in children aged 1–8
years. Risk of deficiency increased significantly with age until age 30 in males and age 18 in
females, after which it did not change significantly with age.
3. NCHS Data Brief ■ No. 59 ■ March 2011
■ 3 ■
What is the prevalence of serum 25OHD values indicating risk of
inadequacy, by age and sex?
The season-adjusted prevalence at risk of inadequacy by age ranged from 9% to 28% in males
and 11% to 28% in females (Figure 3). In both sexes, the prevalence was lowest in children aged
1–8 years. Risk of inadequacy increased significantly with age until age 30 in males, after which
it did not change further with age. Risk of inadequacy increased significantly with age until age
14 years in females. After age 14, risk of inadequacy among females remained constant until
age 51, when it increased significantly. After the increase at age 51, risk of inadequacy remained
stable in females.
4. NCHS Data Brief ■ No. 59 ■ March 2011
■ 4 ■
Does the prevalence of serum 25OHD values indicating risk of deficiency
and inadequacy differ by sex or race and ethnicity? Among women of
childbearing age, does this prevalence differ by pregnancy and lactation
status?
Males were less likely to be at risk of deficiency than females, after adjusting for age and
season (Figure 4). The age- and season-adjusted prevalence at risk of inadequacy did not differ
by sex. Non-Hispanic white persons were less likely to be at risk of deficiency or at risk of
inadequacy than non-Hispanic black or Mexican American persons, after adjusting for age and
season. According to IOM (1), interpretation of serum 25OHD thresholds for risk of deficiency
or inadequacy in nonwhite persons is uncertain because many nonwhite groups have better
skeletal status than white persons despite having lower serum 25OHD values. Among women of
childbearing age, those who were pregnant or lactating were less likely to be at risk of deficiency
than women who were not pregnant or lactating, after adjusting for age and season. The age- and
season-adjusted prevalence at risk of inadequacy did not differ by pregnancy and lactation status
in women of childbearing age.
5. NCHS Data Brief ■ No. 59 ■ March 2011
■ 5 ■
Has the prevalence at risk of deficiency and inadequacy changed since
the 1990s?
In 1988–1994, 4% of males aged 12 years and over had serum 25OHD values that put them at
risk of deficiency, after adjusting for age and season; in comparison, the age- and season-adjusted
prevalence at risk of deficiency in 2001–2002 increased to 7% (Figure 5). The corresponding
figures for those at risk of inadequacy were 17% and 22%, respectively. The age- and season-
adjusted prevalence at risk of deficiency or inadequacy did not change between 2001–2002 and
2005–2006 in adolescent and adult men.
The age- and season-adjusted prevalence at risk of deficiency also increased between 1988–1994
and 2001–2002 among females aged 12 years and over (Figure 5). In 1988–1994, 7% of females
aged 12 and over were at risk of deficiency, after adjusting for age and season, compared with
11% in 2001–2002. However, the age- and season-adjusted prevalence of adolescent and adult
women at risk of inadequacy decreased from 30% in 1988–1994 to 25% in 2001–2002. The
age- and season-adjusted prevalence at risk of deficiency or inadequacy did not change between
2001–2002 and 2005–2006 in adolescent and adult women.
6. NCHS Data Brief ■ No. 59 ■ March 2011
■ 6 ■
Summary
Most persons in the United States are sufficient in vitamin D, based on serum 25OHD thresholds
proposed by IOM. Roughly one-quarter were at risk of inadequacy and 8% were at risk of
deficiency. The prevalence at risk of deficiency or inadequacy differed by age, sex, and race
and ethnicity. Groups at lower risk included children, males, non-Hispanic white persons,
and pregnant or lactating women. Between 1988–1994 and 2001–2002, the prevalence at risk
of deficiency increased in adolescents and adults of both sexes, but the prevalence at risk of
deficiency or inadequacy did not change between 2001–2002 and 2005–2006.
Definitions
At risk of vitamin D deficiency: Serum 25OHD less than 30 nmol/L (12 ng/mL) (1).
At risk of vitamin D inadequacy: Serum 25OHD 30–49 nmol/L (12–19 ng/mL) (1).
Sufficient in vitamin D: Serum 25OHD 50–125 nmol/L (20–50 ng/mL) (1).
Possibly harmful vitamin D: Serum 25OHD greater than 125 nmol/L (50 ng/mL) (1).
Season: Two categories, based on month of blood draw: November–March and April–October.
Season is important to consider for two reasons: (i) vitamin D is produced in the skin by sunlight
exposure, so it varies by season; and (ii) for practical reasons, data are collected in NHANES in
the South during the winter and North during the summer.
NHANES III (1988–1994) serum 25OHD adjustment: The assay method used to measure serum
25OHD in NHANES III differed from the method used in NHANES 2001–2006. A statistical
adjustment was applied to the NHANES III serum 25OHD so that the data could be validly
compared with serum 25OHD from NHANES 2001–2006. Details about the adjustment have
been published elsewhere (2).
Data source and methods
NHANES data were used for these analyses. NHANES is a cross-sectional survey designed to
monitor the health and nutritional status of the civilian noninstitutionalized U.S. population (3).
The survey consists of interviews conducted in participants’ homes and standardized physical
examinations that include laboratory tests utilizing blood and urine specimens provided by
participants during the examination.
The NHANES sample is selected through a complex, multistage design that includes selection of
primary sampling units (counties), household segments within the counties, and finally sample
persons from selected households. The sample design includes oversampling to obtain reliable
estimates of health and nutritional measures for population subgroups. In 1988–1994 and 2001–
2006, non-Hispanic black and Mexican-American persons were oversampled. In 1999, NHANES
became a continuous survey, fielded on an ongoing basis. Each year of data collection is based on
a representative sample covering all ages of the civilian noninstitutionalized population. Public-
use data files are released in 2-year cycles.
7. NCHS Data Brief ■ No. 59 ■ March 2011
■ 7 ■
Sample weights, which account for the differential probabilities of selection, nonresponse,
and noncoverage, were incorporated into the estimation process. The standard errors of the
percentages were estimated using Taylor series linearization, a method that incorporates the
sample weights and sample design. Prevalence estimates were age adjusted to the 2000 U.S.
standard population using the following age groups: ages 1–8, 9–19, 20–39, 30–49, 50–69, and
70 and over (Figure 4; data by sex and race and ethnicity); ages 12–24, 25–34, and 35–44
(Figure 4; data by pregnancy or lactation status); and ages 12–29, 30–49, 50–69, and 70 and over
(Figure 5). Serum 25OHD data were statistically adjusted for season when making comparisons
by age, sex, race and ethnicity, and pregnancy or lactation status, to control for differences in
the time of year when blood was drawn in different groups. Differences between groups were
evaluated using a t statistic at the p < 0.05 significance level. Tests of trends were done using the
p < 0.05 significance level. All results presented have a relative standard error
All differences reported are statistically significant unless otherwise indicated. Statistical analyses
were conducted using the SAS System for Windows (release 9.2; SAS Institute, Cary, NC) and
SUDAAN (release 10.0; Research Triangle Institute, Research Triangle Park, NC).
About the authors
Anne C. Looker, Clifford L. Johnson, and David A. Lacher are with the Centers for Disease
Control and Prevention’s (CDC) National Center for Health Statistics, Division of Health and
Nutrition Examination Surveys. Christine M. Pfeiffer and Rosemary L. Schleicher are with
CDC’s National Center for Environmental Health, Division of Laboratory Sciences. Christopher
T. Sempos is with the National Institutes of Health, Office of Dietary Supplements.
References
Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC:1.
National Academies Press. 2010.
Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-2.
hydroxyvitamin D status of the U.S. population: 1988–1994 compared with 2000–2004. Am J
Clin Nutr 88(6):1519–27. 2008.
National Center for Health Statistics. National Health and Nutrition Examination Survey,3.
2001–2006. Available from: http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm.
Accessed February 25, 2011.
8. NCHS Data Brief ■ No. 59 ■ March 2011
Suggested citation
Looker AC, Johnson CL, Lacher DA, et al.
Vitamin D status: United States, 2001–2006.
NCHS data brief, no 59. Hyattsville, MD:
National Center for Health Statistics. 2011.
Copyright information
All material appearing in this report is in
the public domain and may be reproduced
or copied without permission; citation as to
source, however, is appreciated.
National Center for Health
Statistics
Edward J. Sondik, Ph.D., Director
Jennifer H. Madans, Ph.D., Associate
Director for Science
Division of Health and Nutrition
Examination Surveys
Clifford L. Johnson, M.S.P.H., Director
U.S. Department of
Health & Human Services
Centers for Disease Control and Prevention
National Center for Health Statistics
3311 Toledo Road
Hyattsville, MD 20782
Official Business
Penalty for Private Use, $300
To receive this publication regularly, contact the
National Center for Health Statistics by
calling 1–800–232–4636
E-mail: cdcinfo@cdc.gov
Internet: http://www.cdc.gov/nchs
First Class mAIL
Postage & Fees Paid
CDC/NCHS
Permit No. G-284
ISSN 1941–4927 (Print ed.)
ISSN 1941–4935 (Online ed.)
CS221202
T38775 (03/2011)
DHHS Publication No. (PHS) 2011–1209